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Toxoplasma gondii has an unusual population structure consisting of three clonal lineages that predominate
in North America and Europe. This simple pattern has encouraged the use of only a few laboratory isolates that
are representative of each lineage. Principle among these is the type I RH strain, originally isolated from a
child with encephalitis some 70 years ago. Comparison of different passages of the RH strain that have been
propagated differently over the intervening time period revealed that the commonly used clonal line called
RH-ERP was not representative of natural isolates of the type I lineage. Notably, RH-ERP formed much larger
plaques than other type 1 strains, including a separate, earlier derived isolate of the RH strain. The RH-ERP
variant also showed enhanced extracellular survival, faster growth, and decreased differentiation compared to
the prototype type I strain GT1. Comparison of gene expression differences in the RH-ERP line revealed that
several ABC transporters were upregulated, which may provide a growth advantage in vitro. These findings
illustrate that dramatic phenotypic changes can arise in laboratory strains, emphasizing the need for com-
parison with recent clinical isolates.
Toxoplasma gondii is a widespread protozoan parasite in the
phylum Apicomplexa, an ancient group of protozoan parasites
containing more than 5,000 species (27). T. gondii infects a
wide range of warm-blooded animals and, while not part of the
natural transmission, human infections can lead to severe dis-
ease in immunocompromised individuals (19). Using a unique
form of actin-based motility, T. gondii penetrates host cells,
where it rapidly multiplies within a nonfusigenic vacuole and
eventually causes lysis of the host cell (44). During the acute
phase of the infection, repeated cycles of cell invasion, repli-
cation, and lysis contribute to rapid spread and tissue damage
(2, 28). In addition to this rapid lytic form of growth, asexual
replication by slow-growing bradyzoites contributes to long-
term chronic infection in a variety of hosts (52). In contrast,
sexual development occurs only in the intestinal epithelial cells
of cats (11). Despite this sexual phase in the life cycle, T. gondii
maintains a highly clonal population structure that consists of
three lineages type I, II and III, which predominate in North
America and Europe (1, 17). These three clonal lineages are
the result of recent expansion from either a genetic bottleneck
or selective sweep that occurred within the last 10,000 years
(48). Within each lineage, all strains are thought to be genet-
ically identical except for random mutations that have oc-
curred since their recent origin. Differences between the three
clonal lineages of T. gondii are also limited, and they display
only 1 to 2% divergence at the nucleotide level for most loci
(6). Despite this similarity, the different clonal lineages differ
dramatically in biological traits such as growth (37), migration
(2), and pathogenesis in laboratory mice (28). The type I lin-
eage has been shown to exclusively contain those strains of T.
gondii that are acutely virulent in laboratory mice (43, 49). The
lethal dose of type I strains in outbred mice is estimated to be
a single organism based on limiting dilution studies, whereas
types II and III have 50% lethal dose that are 4 logs higher
than this. It has been suggested that the virulence of type I
strains may be due to continuous laboratory passage (12).
However, more than 20 natural isolates that share this clonal
genotype and acute virulence phenotype have been described
(43, 49), indicating that acute virulence is genetically encoded
and not simply a consequence of passage history. Consistent
with this, genetic mapping has recently revealed that the acute
virulence of type I strains in the mouse model is controlled by
the rhoptry protein ROP18, which encodes a secretory serine
threonine kinase (50). ROP18 shows dramatic levels of poly-
morphism and, although highly expressed in the type I and II
lineages, it is expressed at very low levels in the type III lineage
owing to the presence of an ancestral upstream region that
influences expression (23).
The commonly used type I strain known as RH was origi-
nally isolated by Albert Sabin from a child who died with
toxoplasmic encephalitis in 1939 (40). The RH strain was re-
ported to be virulent on primary inoculation in laboratory mice
(40). Since then, it has been serially passaged in mice by many
laboratories. The RH strain was adapted for in vitro culture ca.
1977 by Elmer Pfefferkorn, who generated a clonal line that
has also been widely distributed (36). This RH-ERP line was
used to develop procedures for plaque formation on monolay-
ers of host cells, providing a very useful in vitro assay that
captures a combination of invasion, replication, egress, and
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spread. The ability of T. gondii to form such plaques has been
used to generate temperature sensitive mutants (36), define
the molecular basis of various chemically derived mutants (33–
35), test drug sensitivity of parasite strains (29, 30), develop
genetic transformation (45), and to test the phenotype of gene
knockouts (20).
In the 70 plus years since its isolation, the RH strain has
been widely distributed and become the most commonly used
laboratory strain. Previous genetic analysis has shown that,
whereas type I strains are highly similar, isolates of RH ob-
tained from different laboratories show minor genetic differ-
ences in some polymorphic DNA markers (18). This likely
reflects minor genetic drift; however, the significance of these
relatively small differences is unclear. To determine whether
long-term in vitro passage may have affected growth, we com-
pared a number of type I strains by using a plaque formation
assay. Surprisingly, this comparison revealed that the clonal
isolate RH-ERP differed substantially in plaque size from
other type I strains. Additional differences were apparent in
extracellular survival after egress, growth rate, differentiation,
and changes in gene expression. Our findings indicate that the
isolation of cloned lines can give rise to variants that are no
longer representative of natural isolates, demonstrating the
plasticity of phenotypic traits and limiting the utility of labo-
ratory isolates.
MATERIALS AND METHODS
Parasite strains. The RH strain was originally isolated from a child with a
lethal case of encephalitis in 1939 (40) and has since been propagated by con-
tinuous passage in mice or in vitro. We compared several lines that were derived
from this original isolate, as diagramed in Fig. 1. A number of isolates were
obtained from E. Pfefferkorn, Dartmouth Medical School, who acquired the RH
strain from Ben Kean, Cornell University Medical School (36). The oldest of
these is a clonal line that was derived from a single plaque on human foreskin
fibroblast (HFF) cells in ca. 1977 (referred to as RH-ERP77) (36) (Fig. 1). This
isolate was passaged serially on HFF monolayers until 1988, when it was cryo-
preserved (referred to as RH-ERP88). Both the original clone RH-ERP77 and
the later isolate RH-ERP88 were cryopreserved in liquid N2 until the start of the
present study. Continuous growth of this original isolate by serial passage on
HFF monolayers was also used for comparison (referred to here as RH-
ERP2009). The RH-JSR strain is a noncloned line of the original RH isolate that
was obtained in 1988 from Jack Remington, Stanford University School of
Medicine. It was adapted to growth on HFF monolayers by brief passage (i.e.,
several months) and cryopreserved prior to use. The type I GT1 strain, obtained
as oocysts from J. P. Dubey, U.S. Department of Agriculture, Beltsville, MD, was
originally isolated from skeletal muscle of a goat in 1980 (10), and it was adapted
to growth in vitro on HFF cells. For the majority of experiments conducted here,
we used a high-passage isolate of GT1 that had been serially passaged from 30
to 100 times since primary isolation. In selected experiments, we used a low-
passage isolate (within five to six passages since primary isolation), and in these
cases the strain is designated GT1-LP. In addition, we analyzed six other type I
strains (MOR, ENT, VEL, GIL, FAJI, and PT) that were isolated from human
congenital infections, as described previously (Table 1) (9, 17). The precise
passage histories of these isolates are not known but did not exceed30 passages
in vitro, once obtained by our laboratory.
Growth and harvest of parasites. Parasites were propagated in vitro in HFF
cells grown in complete medium—Dulbecco modified Eagle medium containing
10% fetal bovine serum (FBS), 10 mM HEPES (pH 7.4), 1 mM glutamine, and
10 g of gentamicin/ml—under 5% CO2 at 37°C. To assure high levels of
viability, monolayers of HFF cells were inoculated at a high multiplicity of
infection ( 5:1), leading to synchronous lysis at40 h postinoculation. Parasites
were harvested by mechanical scraping at the point where natural egress had
reached  75%. In separate studies we have determined that this provides
maximum viability for subsequent in vitro assays (data not shown). Parasites were
concentrated by centrifugation at 400  g for 10 min after filtration using
3.0-m-pore-size polycarbonate filters (GE Water and Process Technologies,
Tevose, PA), as described previously (39).
FIG. 1. Schematic representation of propagation history of RH
since it was isolated in 1939 (40). RH-JSR was maintained in mice
since primary isolation, adapted for in vitro culture in 1988, and then
cryopreserved. The RH strain was cloned by E. Pfefferkorn, Dart-
mouth Medical School, in 1977 to generate RH-ERP77 (36), which has
been cryopreserved since. RH-ERP88 was propagated continuously
until 1988 and then cryopreserved, whereas RH-ERP2009 was main-
tained by continuous passage in vitro.
TABLE 1. Genotypes of T. gondii strains used in this study
Strain Host Yr Geographic sourceb
H
ap
lo
gr
ou
p Allele at indicated locusc
ATCC
no.a Reference
SA
G
1
SA
G
2
85
0
R
O
P
1
L
32
8
62 c2
9-
2
B
SR
4
SA
G
5C
P
K
1
C
S3
A
K
10
4
SR
S1
G
R
A
6
A
K
37
RH-ERP88d Human 50838 1939 OH 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
RH-JSR Human 17 1939 OH 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
GT1 Goat 50853 1980 MD 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
MOR Human (CTe) 50851 1988 Nantes, France 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
ENT Human (CT) 50850 1985 Strasbourg, France 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
VEL Human (AIDS) 50852 1988 CA 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
GIL Human (CT) 9 1988 Nantes, France 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
FAJI Human (CT) 9 1991 Paris, France 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
PT Human (CT) 9 1983 Toulouse, France 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
a ATCC, American Type Culture Collection.
b OH, Ohio; MD, Maryland; CA, California.
c As defined previously (17).
d The same genotype was obtained for RH-ERP77 and RH-ERP2009.
e CT, congenital toxoplasmosis.
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RFLP genotyping. Parasites were genotyped by multilocus restriction fragment
length polymorphism (RFLP) analysis based on 15 polymorphic markers—
SAG1, SAG2, 850, ROP1, L328, 62, c29-2, BSR4, SAG5C, PK1, CS3, AK104,
SRS1, GRA6, and AK37—as described previously (17). Amplified PCR products
were digested with appropriate restriction enzymes, and the resulting fragments
were separated by electrophoresis in 3% agarose gels, stained with ethidium
bromide, and imaged with an Alpha Imager version 5.5 camera (Alpha Innotech
Corp., San Leandro, CA).
Plaque assay. HFF cells were grown to confluence in six-well plates in com-
plete medium and infected with 200 T. gondii tachyzoites in each of three wells
per isolate. Plates were incubated in complete medium 7 days under 5% CO2 at
37°C without movement so that individual plaques were obtained. After incuba-
tion, infected monolayers were fixed with 70% ethanol and stained with crystal
violet (0.1%) (Sigma-Aldrich, St. Louis, MO). Plaque size was determined by
measurement of 50 plaques from randomly selected microscopic fields that were
examined by using a Zeiss Axioscope (Carl Zeiss, Inc., Thornwood, NY)
equipped with a calibrated ocular micrometer. The area of the plaques was
estimated from the formula: area ab, where a and b are half of the length and
width, respectively, of an oval-shaped plaque. Values were expressed as means
the standard errors of the mean (SEM) from three separate experiments.
Intracellular growth assay. Monolayers of HFF cells grown on triplicate
12-mm coverslips (FisherBrand, Pittsburgh, PA) were challenged with freshly
isolated parasites in Dulbecco modified Eagle medium containing 1% FBS,
incubated for 1 h at 37°C, washed, and incubated for 30 h at 37°C with complete
medium, as described previously (50). After infection, monolayers were fixed and
permeabilized in 4% formaldehyde and 0.25% Triton X-100 in phosphate-buff-
ered saline (PBS) for 20 min. The coverslips were blocked by two 10-min incu-
bations with 5% fetal bovine serum and 5% FBS and incubated for 1 h with
directly conjugated MAb DG52 to SAG1 in 1% FBS. The slides were washed
three times with PBS and mounted in Vectashield with DAPI (4,6-diamidino-
2-phenylindole; Vector Laboratories, Inc., Burlingame, CA) and examined with
a Zeiss Axioscope equipped with epifluorescence. The number of parasites per
vacuole was determined by counting 50 vacuoles per coverslip (three coverslips
per sample) and was expressed as means  the SEM from three separate
experiments.
Extracellular survival assay. Parasite survival following natural egress was
estimated by counting the number of plaques formed on monolayers of HFF
cells. Freshly egressed parasites were incubated for defined intervals in complete
medium at 37°C and then inoculated onto fresh monolayers of HFF cells and
allowed to grow for 7 days, as described above. Values were expressed as
means  the SEM from three separate experiments.
Virulence assay. Eight-week-old female CD-1 outbred mice (Charles River
Laboratories, Wilmington, MA) were injected intraperitoneally with tachyzoites
and monitored for 30 days. For each parasite strain, mice were infected with 10,
100, or 1,000 tachyzoites (10 animals/dose), and survival was monitored. The
strains were also tested for viability in parallel by performing a plaque assay, and
the results of this assay were used to normalize the infectious doses used in vivo.
At the end of the 30-day observation period, mice were bled, and the sera were
tested by Western blotting for antibodies against T. gondii. Sera were diluted
1:100 in PBS containing 1% nonfat dry milk and used to probe blots of GT1
strain lysate that had been separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and transferred to a nitrocellulose membrane. Primary anti-
bodies were detected by horseradish peroxidase-conjugated goat anti-mouse
immunoglobulin G (Amersham Pharmacia/GE Healthcare, Piscataway, NJ), di-
luted 1:10,000, and enhanced chemiluminescent substrate (ECL Plus; GE
Healthcare), followed by exposure to film.
In vitro differentiation of T. gondii strains. In vitro bradyzoite induction was
performed by using alkaline treatment of parasites grown in confluent monolay-
ers of HFF cells cultured on coverslips, as described previously (47). Coverslips
were infected with tachyzoites of each strain and differentiation was induced by
culture in sodium bicarbonate-free RPMI 1640 containing 1% FBS–HEPES (pH
8.1) at 37°C without CO2. Cultures were incubated for 7 days with replacement
of the medium every 2 to 3 days. After incubation, coverslips were fixed in 4%
formaldehyde containing 0.25% Triton X-100 in PBS for 20 min. The coverslips
were washed with PBS and blocked by two 10-min incubations with 5% fetal
bovine serum and 5% FBS in PBS. Cysts were stained with fluorescein isothio-
cyanate-labeled Dolichos biflorus lectin (DBL; Vector Laboratories, Inc., Bur-
lingame, CA) and tachyzoites were stained with monoclonal antibody (MAb)
DG52 to SAG1 that was directly conjugated to Alexa 594 (Molecular Probes/
Invitrogen, Carlsbad, CA). Slides were washed three times with PBS, mounted in
Vectashield with DAPI (Vector Laboratories, Inc.,), and examined with a Zeiss
Axioscope equipped with epifluorescence. Images were captured by using an
AxioCam camera and processed similarly for all samples.
Gene expression microarray of T. gondii. Total RNA was isolated from freshly
egressed parasites by using the Qiagen RNeasy kit, according to the manufac-
turer’s instructions (Qiagen, Valencia, CA). RNA quality was checked by using
an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). A total of
three g of total RNA was transcribed to cRNA by using the Affymetrix One-
Cycle kit (Affymetrix, Santa Clara, CA). Fragmented cRNA (5 g) was hybrid-
ized to the T. gondii Affymetrix microarray (http://roos-compbio2.bio.upenn.edu
/abahl/Array-Tutorial.html), as described previously (3). Hybridizations were
carried out in triplicate from three separately grown samples. After hybridiza-
tion, data were filtered with robust multi-array averaging (RMA), normalized
using per-chip and per-gene median polishing, and analyzed by using the soft-
ware package GeneSpring v7.2 (Agilent Technologies, Santa Clara, CA). Gene
expression plots and heat maps were generated in GeneSpring. We used two
procedures to identify genes differentially regulated between the strains. (i)
Genes were grouped in GeneSpring by “strain” to define statistically significant
differences (P 0.05) using a one-way Welch analysis of variance (ANOVA) and
error model variances. Multiple testing correction was applied by using the
Benjamin and Hochberg false discovery rate. (ii) The raw expression values from
normalized GeneSpring data were compared in significance analysis of microar-
rays (SAM) (http://www-stat.stanford.edu/tibs/SAM/) using the multiclass re-
sponse type with 100 permutations. A delta value of 2.92 was used to generate a
list of genes at a median false discovery rate of 0.05%. Array data were archived
at NCBI Gene Expression Omnibus under accession number GSE16115.
Real-time quantitative reverse transcription-PCR (qRT-PCR). Total RNAs
that had been exacted for the array experiments described above were tran-
scribed into cDNA by using a reaction consisting of 50 M oligo(dT)20, 200 U of
SuperScript III reverse transcriptase (Invitrogen), and 2.5 g of RNA in a
volume of 20 l. Quantitative PCR was carried out using a 25-l reaction mixture
containing 2 SYBR Advantage quantitative PCR premixed (Clontech, Moun-
tain View, CA), 10 M concentrations of each primer, and 2 l of cDNA.
Quantitative PCR was performed by using a Smart Cycler (Cepheid, Sunnyvale,
CA) with gene-specific primers, designed using Primer Express software (version
1.0; Applied Biosystems, Foster City, CA). The reaction conditions were 95°C for
45 s, followed by 40 cycles of 95°C for 5 s and 62°C for 30 s. The data analysis was
performed by using SmartCycler software (Cepheid). The relative gene expres-
sion levels were calculated as the fold change by using the formula 2		CT, where
	CT the threshold cycle (CT) of a control gene the CT of the target gene and
		CT  the 	CT of the reference strain (i.e., RH-ERP2009 cDNA)  the 	CT
of either of the strains GT1 or RH-JSR. Actin (gene ID TGME49_009030) or
GAPDH (glyceraldehyde-3-phosphate dehydrogenase; gene ID TGME49_
089690) were used as controls.
Sequence analysis. The genomic sequences of chromosomes Ia and Ib for GT1
and RH-ERP strains were obtained from ToxoDB.org (http://toxodb.org/toxo
/home.jsp) (15). The GT1 sequence was generated previously by the Institute for
Genomic Research, while the Wellcome Trust Sanger Institute generated the
RH-ERP sequence. The ends of the chromosomes were removed by deleting the
sequences past the end of the first and last annotated genes. Differences were
identified by comparison of the genome sequences with MUMmer 3.21 using
the dnadiff script and default options (26).
Animal care and housing. Animals were cared for by the Division of Com-
parative Medicine, and the Animal Studies Committee at Washington University
approved all procedures conducted.
Statistical analysis. Statistical analysis was performed using formulae pro-
vided in Microsoft Excel. Triplicate experiments were performed and the means,
standard deviation, and standard error means were calculated for statistical
comparisons. The Student t test was used to determine the significance level
under the assumptions of two separate means with equal variance and using a
two-tailed test. The frequency of different classes of genes within the differen-
tially expressed gene list was compared to the whole genome using a hypergeo-
metric distribution with the HYPGEOMDIST function in Excel.
RESULTS
Formation of plaques by different type I strains. Because of
the lytic growth pattern of tachyzoites, T. gondii forms plaques
efficiently on monolayers of host cells in vitro, and this provides
a useful measure of viability (36). Initially, we compared the
size of plaques formed among different type I strains (Table 1).
Somewhat surprisingly, we observed a dramatic difference in a
common laboratory isolate of RH (referred to here as RH-
ERP2009), which formed much larger plaques than the other
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type I strains (Fig. 2A). Although plaques formed by the other
type I strains, including GT1, were not as large as those formed
by RH-ERP2009, they were easily recognizable when exam-
ined under a microscope (Fig. 2A). Measurement of the aver-
age plaque area revealed that RH-ERP2009 developed signif-
icantly (P  0.00005) larger plaques than GT1 or a collection
of other type I isolates (Fig. 2B). We considered that this
difference might reflect the very different passage history of
RH-ERP2009, compared to the other type I strains, which are
relatively recent isolates (Table 1). RH-ERP2009 differs from
these primary clinical isolates and other RH lines in two ways.
First, it was obtained by subcloning the original RH line to
isolate a line that grew well on HFF cells in vitro (36) (Fig. 1).
Second, it has been maintained since ca. 1977 by continuous
passage at 2-day intervals on HFF cell monolayers. In contrast,
many other laboratories utilize RH lines that are passaged in
mice (18). Since the plaque-forming assay is performed on
HFF cells, the larger plaque size may reflect an adaptation to
growth on this particular host cell or be a result of long-term
passage history. To decipher between these alternatives, we
compared the original RH clone that was isolated in 1977
(referred to as RH-ERP-77) to an isolate that was passaged for
approximately 10 years in vitro (referred to as RH-ERP88) and
to a mouse-passaged line that was propagated continuously
since the original isolation in 1939 and then briefly adapted to
growth on HFF cells (referred to as RH-JSR) (Fig. 1). Inter-
esting, we observed that RH-JSR formed smaller plaques like
GT1, whereas RH-ERP77 and RH-ERP88 formed larger
plaques like RH-ERP2009 (Fig. 2B). A low-passage isolate
called GT1-LP also developed smaller plaques like GT1. The
large-plaque phenotype was also not unique to all RH strain
isolates but rather was only expressed by derivatives of the
clone that was isolated by Elmer Pfefferkorn in 1977 (36).
The additional type I isolates used for comparison above
were obtained from human congenital cases of toxoplasmosis
in the United States and Europe (Table 1). The data in Table
1 indicate that these strains match the type I genotype at all 15
loci examined, making it extremely probable that they are
members of this clonal lineage, rather than diverse genotypes.
Although they provide recent clinical isolates of the type I
lineage for comparison, their capacity to complete the life cycle
and genetic makeup has not been extensively studied. Because
GT1 has a similar genotype and phenotype to natural type I
isolates and yet it is more completely characterized, we utilized
GT1 as a representative type I strain for further comparison
with RH-ERP2009. The GT1 strain is capable of completing
the entire life cycle, has been used in several genetic crosses
(24, 49), and is the isolate used for whole genome sequencing
for the type I lineage (http://ToxoxdDB.org/).
Comparison of intercellular growth rates. Previous studies
have shown that the intracellular growth rate of T. gondii
differs substantially between different strain types (38). To
evaluate the difference in growth rate between RH-ERP2009
and GT1, we measured the rate of intracellular replication
indirectly by evaluating the number of parasites within individ-
ual vacuoles at 30 h postinfection, prior to natural egress and
reinvasion. GT1 lagged behind RH and the number of vacu-
oles with 16 parasites was significantly higher (P  0.05) in
GT1 than RH-ERP2009, while the number of vacuoles with 32
parasites was significantly higher (P  0.005) in RH-ERP2009
than GT1 (Fig. 3A). As a consequence, the average number of
parasites per vacuole was also significantly higher (P 0.05) in
RH-ERP2009 (25.54  0.53) than in GT1 (19.03  0.61).
Collectively, these results are consistent with RH-ERP2009
having a faster division time than GT1 or, alternatively, with
GT1 having a considerable lag in the onset of division after cell
invasion.
Survival after natural egress. At the culmination of the
intracellular cycle, tachyzoites emerge from the host cell by a
process of natural egress, defined here as 75% lysis of host
cell monolayers. Extracellular parasites are unable to replicate
and remain viable for only a limited period of time. We tested
the extracellular survival of RH-ERP2009 versus RH-JSR,
GT1, and GT1-LP by incubating freshly egressed parasites at
37°C for various intervals, followed by plaquing on fresh mono-
layers of HFF cells. Interestingly, fewer numbers of GT1
tachyzoites were viable at the outset compared to RH-
ERP2009 (P  0.005) (Fig. 3B). There was a significant (P 
0.005) decrease in the survival rate for GT1 within a 12-h
period, whereas it took 24 h for a similar decrease to be
observed for RH-ERP2009 (Fig. 3B). There was also a signif-
icant difference in survival between low- and high-passaged
parasites. The high-passage GT1 isolate showed higher initial
FIG. 2. Plaque formation assay using different type I strains.
(A) Example of plaques formed by RH-ERP2009 and GT1 when
grown on HFF monolayers in six-well plates. On the left is a low-
magnification image of one entire well. Scale bar, 1 cm. The image on
the right was obtained by microscopic examination and shows a single
plaque formed by GT1. Scale bar, 0.2 mm. (B) Quantification of the
area of plaques developed by RH-ERP2009 and other type I strains.
Plaques developed by RH-ERP77, RH-ERP88, and RH-ERP2009
were significantly (P  0.005) larger than other type I strains including
from RH-JSR. Values are means  the SEM (n  three separate
experiments, 50 plaques/experiment) for RH-ERP77, RH-ERP88,
RH-ERP2009, GT1, and GT1-LP, and means  the standard devia-
tion (SD) for each of two experiments, for remaining isolates.
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viability and survived significantly better than the low-passage
isolates GT-LP or RH-JSR (Fig. 3B). Collectively, these data
indicated that the RH-ERP2009 parasites had a higher initial
viability, survived for a prolonged time period (more than 24 h)
outside the host cell, and were still able to invade new host
cells.
In vitro induction of bradyzoite. The finding that GT1
formed smaller plaques in vitro could result from spontaneous
differentiation into slow-growing bradyzoites within tissue cysts
during the 7-day incubation period. To check this possibility,
we monitored cyst conversion by labeling with the fluorescent
lectin DBL, which stains the cyst wall (25). First, we checked
whether RH-ERP2009 and GT1 were able to undergo differ-
entiation in response to stress. After in vitro induction under
alkaline pH-induced stress for 7 days, GT1 stained strongly
with DBL, indicating development of a normal cyst wall (Fig.
4). In contrast, RH-ERP2009 did not stain with DBL, indicat-
ing it failed to differentiate (Fig. 4). Despite readily differen-
tiating under inducing conditions, GT1 failed to stain with
DBL during growth in normal medium, which simulates the
conditions used for plaque formation (Fig. 4). These results
reveal that the small-plaque phenotype of GT1, and most prob-
ably the other type I strains as well, was unlikely to be due to
spontaneous differentiation into tissue cysts.
Virulence assay. Although RH-ERP2009 and GT1 are both
type I strains, they differed in several in vitro phenotypic traits
monitored above. To determine whether these in vitro pheno-
types had any impact on infection in vivo, we tested virulence
in the mouse model. The acute virulence of RH-ERP2009 and
GT1 was determined from cumulative mortality and serologi-
cal status of surviving mice after intraperitoneal inoculation in
outbred mice, as described previously (49, 50). To control for
viability of the inoculum, tachyzoite survival was determined by
plaque assay, which showed that 20% of RH-ERP2009 were
viable, whereas only 4% of GT1 parasites were viable. Inocu-
lation with different numbers of purified tachyzoites of RH-
ERP2009 resulted in 100% mortality of all infected mice within
12 days (Fig. 5A). In contrast, inoculation of GT1 led to 100%
mortality at an adjusted dose of 4 and 40 tachyzoites but only
limited mortality at an adjusted dose of 0.4 parasites (Fig. 5B).
Animals that survived when challenged with GT1 parasites
remained seronegative (data not shown), indicating that they
did not become infected. When adjusted for the differences
observed in viability, there was essentially no difference in the
mortality induced by the two strains.
FIG. 3. Comparison of intracellular growth and extracellular sur-
vival between strains of T. gondii. (A) Comparison of intracellular
growth rate between RH-ERP2009 and GT1. Monolayers of HFF cells
were infected with parasites, grown for 30 h, fixed, and stained with
MAb DG52 to detect surface antigen SAG1. The average numbers of
parasites present per vacuole was determined by microscopic exami-
nation and counting of 50 vacuoles/coverslip. GT1 contained signifi-
cantly more vacuoles with 16 parasites/vacuole (*, P  0.05), while the
number of vacuoles with 32 parasites was significantly higher in RH-
ERP (**, P  0.005). Values indicate means  the SEM (n  three
separate experiments with three coverslips each). (B) Comparison of
extracellular survival between RH-ERP2009, RH-JSR, and both low-
and high-passage GT1. The number of tachyzoites surviving after
natural egress was determined by incubation of parasites for at 37°C
with CO2 in complete medium and subsequent plaque assay. The
viability of RH-ERP2009 was higher at the outset and viability
dropped by 50% over the next 24 h (**, P  0.005, comparison of 2 h
versus 24 h). The initial viability of GT1 was significantly lower at 0 h after
egress (**, P 0.005), and this dropped further to almost negligible levels
by 12 h after egress (**, P  0.005, comparison of 2 h versus 12 h).
There was also a significant difference in the viability of low passaged
GT1-LP and RH-JSR isolates versus GT1 even at early time points (*,
P 
 0.05). Values are means  the SEM (n  three experiments).
FIG. 4. Differentiation of tissue cysts after in vitro culture. Para-
sites were induced to differentiate by high-pH culture for 7 days (“In-
duced”), and cyst development was detected by staining with fluores-
ceinated lectin DBL (green), followed by MAb to the parasite surface
protein SAG1 conjugated to Alexa 594 (red). GT1 readily formed cysts
under these conditions, whereas RH-ERP2009 did not. Neither strain
converted to tissue cysts under normal growth conditions used for the
plaque assay (“Normal”). All pictures shown were recorded under
similar optical conditions, imaged with the same exposure time, and
processed identically. Scale bars: 15 m in the top panel and 40 m in
the remaining panels.
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Comparison of gene expression profiles between type I iso-
lates. Previous studies have shown that continuous in vitro
passage can result in changes to the global gene expression
profiles in mammalian cells (32). To examine the extent of
gene expression differences between highly homologous type I
strains, we took advantage of the T. gondii Affymetrix microar-
ray containing probes to more than 8,000 genes. We compared
the RH-JSR and GT1 strains, two isolates that share the small
plaque phenotype, to the large plaque isolate RH-ERP2009.
After hybridization and normalization of data, we used two
independent methods to generate lists of genes with expression
differences that were twofold or greater in at least one sample
and statistically significant between the two strains. ANOVA
identified 520 genes that were significantly differentially ex-
pressed between GT1, RH-ERP2009, and RH-JSR (P 0.05).
Independently, SAM (false discovery rate  0.05%) analysis
identified 475 transcripts that were differentially expressed.
The lists were combined to yield 610 distinct genes that were
used to perform pairwise comparisons between the three sam-
ples, with an emphasis on changes in gene expression that
might underlie the phenotypic differences observed in RH-
ERP. Pairwise comparisons identified 113 genes that were
similarly expressed in GT1 and RH-JSR and differentially ex-
pressed in RH-ERP2009 (Fig. 6 and see Table S1 in the sup-
plemental material). Codifferentially expressed genes were lo-
cated across all chromosomes and showed no pattern of
clustering to one particular region of the genome (see Table S1
in the supplemental material). A wide variety of functional
annotations were found in the differentially expressed genes,
including many hypothetical or unknowns. Interestingly, 3 of
FIG. 5. Acute virulence of RH-ERP2009 and GT1 strains as mon-
itored by infection in outbred mice. (A) All animals inoculated with
RH-ERP2009 died within 12 days, regardless of dose. (B) Animals
injected with 4 or 40 tachyzoites of GT1 also died rapidly. Most of mice
injected with 0.4 GT1 tachyzoites survived; however, surviving mice
were not infected, as shown by a negative serological response in
Western blot (*). The results shown are the combination of two ex-
periments with five mice per group each. Inocula have been adjusted
for viability based on efficiency of plaque formation (see Materials and
Methods).
FIG. 6. Global gene expression differences between GT1, RH-ERP2009, and RH-JSR. After hybridization to T. gondii Affymetrix microarrays,
two independent methods were used to identify genes with significant expression differences, and the combined set is shown here graphically. The
color bar at the far right applies to both the heat map (A) and graph (B), where orange/red represents increased expression, and blue indicates
decreased expression relative to RH-ERP2009. (A) Heat map of 113 differentially expressed genes, including 72 that showed greater expression
in GT1 and RH-JSR and 41 that showed greater expression in RH-ERP2009. (B) Graphic display of the differences in gene expression of 113 genes
that showed similar expression in RH-JSR and GT1 but that were upregulated (red) or downregulated (blue) in RH-ERP2009.
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34 ABC transporters (ToxoDB) were significantly upregulated
in RH-ERP2009 relative to both RH-JSR and GT1 (hypergeo-
metric distribution, P  0.01). Comparison of genes that were
unique expressed in other strains also revealed 37 genes that
were significantly different only in GT1 and 177 that were
different only in RH-JSR; however, neither of these sets
showed a similar upregulation of transporters (the raw data
can be retrieved from GEO).
Quantitative PCR analysis of gene expression. To validate
the array data, we also tested a subset of genes by quanti-
tative PCR and compared their expression levels between
RH-ERP, RH-JSR, and GT1. Several hypothetical un-
knowns that showed widely different gene expression levels
were tested using gene specific primers, including one gene
that was predicted to be different among all three strains
(i.e., 540.m00325) and two that were predicted to be selec-
tively upregulated in RH-ERP relative to the other two
strains (i.e., 583.m09210 and 83.m02139). The results of the
quantitative PCR analysis revealed similar trends, although
the magnitudes of the differences were slightly different
(Table 2). We also analyzed three ABC transporters that
were upregulated in the array data for RH-ERP with respect
to RH-JSR and GT1. The predicted differences in upregu-
lation of expression in RH-ERP were verified by quantita-
tive PCR using gene-specific primers (Table 2). We also
tested a fourth ABC transporter that was upregulated in
RH-ERP relative to both RH-JSR and GT1, although in this
case the array data indicated different levels of expression in
all three strains (i.e., 80.m02212). Quantitative PCR analysis
showed that this gene was also upregulated in RH-ERP
relative to both RH-JSR and GT1, albeit to different extents
(Table 2). Collectively, 4 of 34 ABC transporters found in
the genome were selectively upregulated in the RH-ERP
strain, which is unlikely to be due to chance.
DISCUSSION
Previous studies have emphasized the large phenotypic dif-
ferences that occur between lineages of T. gondii, while con-
sidering within lineage variation to be relatively insignificant
(41, 42). We compared here in vitro growth phenotypes, acute
virulence in the mouse model, and gene expression profiles of
several common type I isolates of T. gondii. One clonal isolate,
called RH-ERP, demonstrated a higher growth rate, pro-
longed survival time outside host cells, and greatly increased
plaque size on host cell monolayers. These differences were
common to all of the descendants of this original subclone of
the RH strain. In contrast, another isolate of RH known as
RH-JSR had a small-plaque phenotype, similar to more recent
clinical type I isolates and the animal isolate GT1, which serves
as the reference strain for this lineage. The greater extracellu-
lar survival of RH-ERP led to higher mortality in mice; how-
ever, when adjusted for differences in initial viability, it was
similar to the type I strain GT1. These findings indicate that
despite having a highly conserved genotype, type I strains can
show substantial phenotypic variation and differences in gene
expression.
Plaque formation is commonly used to measure growth of T.
gondii, and this process is the result of several events including
invasion, growth, egress, and migration (39). A previous study
showed that type I strains exhibited a higher migratory capacity
in vitro than either type II or III (2), and other studies have
demonstrated type I strains grow faster in vitro (37). Although
these prior studies might have predicted large phenotypic dif-
ferences between lineages, our findings illustrate dramatic dif-
ferences can also occur within a lineage. Specifically, RH-
ERP2009 grew significantly faster and survived outside the
host cells for a much longer time than GT1, or other small
plaque isolates including the RH-JSR strain. Based on these
results, we expect that RH-ERP would also show increased
motility and invasion into monolayers of host cells, since these
in vitro assays also depend on viability.
RH-ERP was derived by E. Pfefferkorn, Dartmouth Medical
School, who isolated a single plaque from a culture of the RH
strain obtained from B. Kean, Cornell University Medical
School (36). In contrast, RH-JSR is a noncloned line of orig-
inal RH strain that was maintained first at the National Insti-
tutes of Health, Laboratory of Parasitic Diseases, and then at
the Stanford School of Medicine. Since isolation, RH-ERP has
been maintained by growth on monolayers of HFF cells, while
RH-JSR was maintained by serial passage in mice. Hence,
several factors could potentially influence the phenotypic and
gene expression differences observed here. The initial viability,
and hence the efficiency of plaquing, was highly dependent on
passage history. In contrast, the large-plaque phenotype was
TABLE 2. Comparison of gene expression levels by qRT-PCRa
ToxoDB IDb Common name
Fold difference
determined by
microarray
Fold difference determined by qRT-PCRc
Actin GAPDH
RH-JSR GT1 RH-JSR GT1 RH-JSR GT1
540.m00325 Hypothetical protein 3.595 61.594 0.281 46.200 0.413 87.426
49.m03125 Multidrug resistance protein, putative/ABC
transporter
0.243 0.375 0.014 0.188 0.032 0.355
50.m03178 ABC transporter 0.284 0.208 0.002 0.130 0.004 0.246
31.m00887 ABC1 domain-containing protein 0.303 0.223 0.0001 0.076 0.0003 0.145
80.m02212 ABC2 membrane 0.375 0.055 0.014 0.096 0.032 0.182
583.m09210 Hypothetical protein 0.162 0.075 0.012 0.124 0.028 0.235
83.m02139 Hypothetical protein 0.359 0.046 0.007 0.047 0.016 0.088
a Fold differences are determined compared to RH-ERP2009.
b That is, the ToxoDB annotation 3 accession number.
c Actin and GAPDH are normalization controls.
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common to the original cloned isolate RH-ERP77, and all
subsequent isolates derived from it, and was not seen in other
type I strains. These results indicate that the large-plaque phe-
notype was not the result of long-term passage but instead
represents a naturally occurring variant that was fortuitously
chosen in the cloning process. However, we cannot not rule out
the possibility that the RH-ERP line represents a unique type
I lineage that was inadvertently mixed up with the original RH
line. Deep sequencing of the genome of various type I isolates
may eventually allow reconstruction of the ancestry and/or
alteration(s) that led to this phenotype. Regardless of the exact
basis of this trait, the large plaque size of RH-ERP provides an
extremely convenient assay for growth, viability, drug resis-
tance, etc., and so it is easy to appreciate why it would have
been chosen as a laboratory model.
During differentiation into bradyzoites, the cell wall of the
forming tissue cyst stains with DBL, which recognizes N-acetyl-
galactosamine (25). Differentiation can be induced in vitro
using a variety of stress conditions, including cultivation at high
pH (47). After in vitro culture under alkaline pH induction,
RH-ERP2009 failed to stain with DBL, indicating an inability
to undergo cyst wall development, whereas GT1 readily un-
derwent stage conversion, as reported previously (14). The
inability of RH-ERP2009 to express cyst wall markers indicates
that it is impaired in development, which may be a conse-
quence of long-term growth in vitro. Others have reported that
the RH strain can undergo partial bradyzoite development in
vitro under similar conditions (46); however, it is generally
thought that type I strains are less capable of switching than
type II strains (52) or type III strains (3).
The dramatic differences between in vitro growth pheno-
types of type I strains observed here were somewhat surprising
given the recent origin of the clonal lineages estimated at 104
years (48), and the even more recent common origin of the RH
lines, since 1939 (Fig. 1). There are several sources of data that
provide estimates of genetic polymorphisms within the clonal
type I lineages. Genetic differences between RH isolates have
previously been described based on a single nucleotide poly-
morphism detected by RFLP analysis (18). However, a broader
sampling of sequences from introns and housekeeping genes
failed to reveal differences between GT1 and RH-ERP88
(comparison based on 10,963 bp per strain) (22, 23). In addi-
tion, comparison of the entire sequence of chromosome 1a
(Chr1a) and Chr1b derived from the GT1 and RH-ERP88
strain revealed only 24 and 45 SNPs located on Chr1a and
Chr1b, respectively. These values are likely close the sequenc-
ing error rates, but in any case they indicate a very low level of
genetic polymorphism within the clonal type I lineage. By com-
parison, there are 332 SNPs in Chr1a between the type I
(RH-ERP) and type II lineages (ME49) (21). This level is also
quite low since the three lineages inherited the same version of
Chr1a at a recent time in the past, coinciding with the estab-
lishment of the clonal lineages (21). In contrast, the level of
polymorphism on Chr1b between lineages is on the order of 1
change in 100 bp, which is much more similar to the rest of the
genome (21). Collectively, these estimates suggest that the
phenotypic differences between type I strains are unlikely to be
due to sequence differences (i.e., mutations) but more likely
stem from epigenetic differences in gene expression. Recent
studies have emphasized the relative importance of epigenetic
factors in controlling gene expression in T. gondii (5, 16). This
suggests that a great deal of phenotypic variation might be
expected based on passage history or other environmental in-
fluences. Consistent with this, serial passage of a highly virulent
strain of the T. gondii led to attenuation in the mouse model
(31) and, in a separate study, similar attenuation of the strain
called S48 led to a vaccine strain that is used in animals (7, 8).
As well, previously studies have highlighted the rapid loss of
propagation through the cat phase of the life cycle with re-
peated passage of T. gondii strains (13). In this regard, it may
be significant that the transcript for an oocyst wall protein
(ToxoDB accession no. 76.m01650) was significantly underex-
pressed in RH-ERP2009 compared to RH-JSR and GT1 (see
Table S1 in the supplemental material).
Although the molecular basis of the enhanced growth of
RH-ERP is not defined here, differences in gene expression
that were detected suggest a possible explanation. Microarray
hybridizations identified 113 transcripts that were significantly
differentially expressed in RH-ERP2009 relative to both RH-
JSR and GT1. Among the genes that were differentially regu-
lated, four ABC transporters were significantly overexpressed
in RH-ERP versus both RH-JSR and GT1. ABC transporters
use the energy of ATP to catalyze the transport of a variety of
nutrients across biological membranes such as cholesterol and
other lipids (51). Hence, overexpression of transporters might
result in faster growth, increased extracellular survival, and the
formation of larger plaques. Little is known about the function
of such transporters in T. gondii, and future studies designed to
alter the expression of ABC transporters could be used to test
the hypothesis that their selective overexpression may have led
to enhanced growth of RH-ERP.
T. gondii is a ubiquitous parasite of warm-blooded animals
that has become a model organism to study apicomplexan
parasites. The RH strain has most often been used for in vitro
studies since it replicates efficiently, is easily subcloned, and is
readily transfected. Our studies reveal that one reason that the
RH strain is so amenable to experimental manipulation may
relate to differences in the efficiency of in vitro growth. Al-
though this trait is convenient for establishing in vitro assays, it
may not directly mimic natural type I isolates. Hence, findings
made with laboratory isolates will need to be validated in other
more recent clinical isolates, before they can be attributed as
general features of the respective lineage.
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